Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, December 10, 2024.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Bull Market Weakness (+75) - CRNX is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on CRNX as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid CRNX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRNX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRNX
The long-term trend has been UP since Sep 11th, 2023 at 22.490
The intermediate-term trend has been UP since Dec 9th, 2024 at 59.577
The short-term trend has been UP since Dec 4th, 2024 at 58.130
Smart Scan Analysis for CRNX
Based on our trend formula, CRNX is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 58.740 | 59.630 | 56.570 | 56.605 | -2.265 |
| Prev. Close | Volume | Bid | Ask | Time |
| 56.620 | 418425 | 2024-12-09 15:59:59 |
| Year High | 42 | Year High Date | 2018-09-10 |
| Year Low | 19.23 | Year Low Date | 2018-07-18 |
| 52wk High | 62.53 | 52wk High Date | 2024-11-14 |
| 52wk Low | 32.555 | 52wk Low Date | 2023-12-11 |
| Average Volume | 646,718 | Shares Outstanding | 92,738 |
| Market Cap | 425M | Assets | 937,374,000M |
| Liabilities | 104,394,000M | P/E Ratio | -7.20140000 |
| Volatility | 75.6 |